查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1698336

乳房重建市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测

Breast Reconstruction Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 140 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年全球乳房重建市场规模达到 5.153 亿美元，预计 2025 年至 2034 年期间的复合年增长率为 4.9%。推动这一增长的因素包括手术技术的不断进步、越来越多的女性选择乳房切除术后重建手术以及人们对可用治疗方案的认识不断提高。由于患者偏好自然的效果和更快的恢復时间，对脂肪移植技术等微创手术的需求持续成长。此外，越来越多优惠的报销政策和政府支持倡议使得世界各地的患者更容易接受乳房重建手术。

乳房重建市场 - IMG1

3D 列印植入物和生物工程组织支架等尖端技术的整合正在进一步推动市场扩张。人们越来越关注个人化治疗方法和加强植入物安全标准，这导致了重大的产品创新。随着监管框架的发展，製造商在植入物设计中优先考虑生物相容性和耐用性，以确保长期疗效和患者满意度。此外，全球乳癌发生率的上升，加上接受乳房切除术的女性人数的增加，预计将推动未来十年市场的成长轨迹。由于医疗基础设施的改善和可支配收入的增加，新兴市场（尤其是亚太和拉丁美洲）对乳房重建手术的需求正在激增。

市场范围
起始年份 2024
预测年份 2025-2034
起始值 5.153亿美元
预测值 8.691亿美元
复合年增长率 4.9％

乳房重建市场分为不同的产品领域，包括植入物、组织扩张器、去细胞真皮基质和其他相关产品。植入物占据最大的市场份额，2024 年价值为 3.269 亿美元，包括硅胶和盐水乳房植入物。硅胶植入物因其增强的耐用性、凝聚性凝胶配方和纹理表面设计而广受欢迎，这些特性有助于提供更自然的感觉和更高的安全性。植入技术的创新预计将继续影响市场趋势，各公司将投入大量资金进行研发，以改善植入物的寿命和生物相容性。

乳房重建手术大致分为单侧重建和双侧重建。 2024 年，单侧乳房重建市场规模达 2.994 亿美元，预估 2025 年至 2034 年的复合年增长率为 4.5%。该领域的成长主要得益于乳房切除术后对美观对称性的需求不断增长。寻求单侧重建的患者通常注重恢復平衡和获得自然的外观，导致手术量稳定上升。先进手术技术和植入材料的出现进一步促进了该领域的持续扩张。

2024 年美国乳房重建市场产值达 2.198 亿美元，延续前几年的上升趋势。受致力于产品创新和加强安全措施的领先乳房植入物製造商的推动，该领域在 2025 年至 2034 年期间的复合年增长率预计将达到 4.4%。美国市场受益于强大的医疗保健基础设施、较高的患者意识以及完善的报销框架，鼓励更多女性选择重建手术。该地区的公司正专注于技术进步，例如改进植入物纹理和生物工程解决方案，以满足患者和医疗保健提供者不断变化的需求。

目录

第一章：方法论与范围

第二章：执行摘要

第三章：行业洞察

  • 产业生态系统分析
  • 产业衝击力
    • 成长动力
      • 乳癌发生率不断上升
      • 人们对重建手术的认识不断提高
      • 植入物和网片的技术进步
      • 美容整形手术激增
    • 产业陷阱与挑战
      • 乳房重建手术费用高昂
      • 手术风险和併发症
  • 成长潜力分析
  • 监管格局
    • 我们
    • 欧洲
  • 技术格局
  • 报销场景
  • 波特的分析
  • PESTEL 分析
  • 差距分析
  • 未来市场趋势
  • 价值链分析

第四章：竞争格局

  • 介绍
  • 公司矩阵分析
  • 公司市占率分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 策略仪表板

第五章：市场估计与预测：按产品，2021 - 2034 年

  • 主要趋势
  • 植入物
    • 硅胶乳房植入物
    • 盐水乳房植入物
  • 组织扩张器
  • 去细胞真皮基质
  • 其他产品

第六章：市场估计与预测：按类型，2021 - 2034 年

  • 主要趋势
  • 单侧乳房重建
  • 双侧乳房重建

第七章：市场估计与预测：按程序，2021 - 2034 年

  • 主要趋势
  • 即时
  • 延迟
  • 修订

第八章：市场估计与预测：依最终用途，2021 - 2034 年

  • 主要趋势
  • 医院
  • 门诊手术中心
  • 其他最终用途

第九章：市场估计与预测：按地区，2021 - 2034 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第十章：公司简介

  • AbbVie
  • arion LABORATORIES
  • BIMINI HEALTH TECH
  • CEREPLAS
  • Establishment Labs
  • GC Aesthetics
  • HANSBIOMED
  • INTEGRA
  • Johnson & Johnson
  • POLYTECH Health & Aesthetics
  • RTI Surgical
  • Sebbin
  • Sientra
  • SILIMED
  • Wanhe
简介目录
Product Code: 13238

The Global Breast Reconstruction Market reached USD 515.3 million in 2024 and is projected to expand at a CAGR of 4.9% between 2025 and 2034. This growth is fueled by continuous advancements in surgical techniques, an increasing number of women opting for reconstructive procedures post-mastectomy, and a rise in awareness about available treatment options. The demand for minimally invasive procedures, such as fat grafting techniques, continues to grow, driven by patient preference for natural-looking results and quicker recovery times. Additionally, an increasing number of favorable reimbursement policies and government support initiatives have made breast reconstruction more accessible to patients worldwide.

Breast Reconstruction Market - IMG1

The integration of cutting-edge technologies, including 3D-printed implants and bioengineered tissue scaffolds, is further driving market expansion. The growing focus on personalized treatment approaches and enhanced implant safety standards has led to significant product innovations. As regulatory frameworks evolve, manufacturers are prioritizing biocompatibility and durability in their implant designs, ensuring long-term efficacy and patient satisfaction. Moreover, the rising prevalence of breast cancer globally, coupled with an increase in the number of women undergoing mastectomy procedures, is expected to fuel the market's upward trajectory over the next decade. Emerging markets, particularly in Asia-Pacific and Latin America, are experiencing a surge in demand for breast reconstruction procedures due to improved healthcare infrastructure and rising disposable incomes.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$515.3 Million
Forecast Value$869.1 Million
CAGR4.9%

The breast reconstruction market is categorized into various product segments, including implants, tissue expanders, acellular dermal matrices, and other related products. Implants hold the largest market share, valued at USD 326.9 million in 2024, and include both silicone and saline breast implants. Silicone implants have gained substantial popularity due to their enhanced durability, cohesive gel formulations, and textured surface designs, which contribute to a more natural feel and improved safety profiles. Innovations in implant technology are expected to continue shaping market trends, with companies investing heavily in research and development to refine implant longevity and biocompatibility.

Breast reconstruction procedures are broadly classified into unilateral and bilateral reconstructions. In 2024, the unilateral breast reconstruction segment accounted for USD 299.4 million and is anticipated to grow at a CAGR of 4.5% from 2025 to 2034. This segment's growth is primarily driven by an increasing demand for aesthetic symmetry following mastectomy. Patients seeking unilateral reconstruction are often focused on restoring balance and achieving a natural appearance, leading to a steady rise in surgical volumes. The availability of advanced surgical techniques and implant materials is further contributing to the segment's sustained expansion.

The U.S. Breast Reconstruction Market generated USD 219.8 million in 2024, continuing its upward trend from previous years. This segment is set to grow at a CAGR of 4.4% between 2025 and 2034, driven by the presence of leading breast implant manufacturers dedicated to product innovation and enhanced safety measures. The U.S. market benefits from a strong healthcare infrastructure, high patient awareness, and a well-established reimbursement framework that encourages more women to opt for reconstructive procedures. Companies in the region are focusing on technological advancements, such as improved implant textures and bioengineered solutions, to meet the evolving needs of both patients and healthcare providers.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of breast cancer
      • 3.2.1.2 Growing awareness about reconstructive surgery
      • 3.2.1.3 Technological advancements in implants and mesh
      • 3.2.1.4 Surge in cosmetic and aesthetic procedures
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost of breast reconstruction procedures
      • 3.2.2.2 Surgical risks and complications
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 U.S.
    • 3.4.2 Europe
  • 3.5 Technology landscape
  • 3.6 Reimbursement scenario
  • 3.7 Porter’s analysis
  • 3.8 PESTEL analysis
  • 3.9 Gap analysis
  • 3.10 Future market trends
  • 3.11 Value chain analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Implants
    • 5.2.1 Silicone breast implants
    • 5.2.2 Saline breast implants
  • 5.3 Tissue expander
  • 5.4 Acellular dermal matrix
  • 5.5 Other products

Chapter 6 Market Estimates and Forecast, By Type, 2021 - 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Unilateral breast reconstruction
  • 6.3 Bilateral breast reconstruction

Chapter 7 Market Estimates and Forecast, By Procedure, 2021 - 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Immediate
  • 7.3 Delayed
  • 7.4 Revision

Chapter 8 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals
  • 8.3 Ambulatory surgical centers
  • 8.4 Other End Use

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE

Chapter 10 Company Profiles

  • 10.1 AbbVie
  • 10.2 arion LABORATORIES
  • 10.3 BIMINI HEALTH TECH
  • 10.4 CEREPLAS
  • 10.5 Establishment Labs
  • 10.6 GC Aesthetics
  • 10.7 HANSBIOMED
  • 10.8 INTEGRA
  • 10.9 Johnson & Johnson
  • 10.10 POLYTECH Health & Aesthetics
  • 10.11 RTI Surgical
  • 10.12 Sebbin
  • 10.13 Sientra
  • 10.14 SILIMED
  • 10.15 Wanhe